Literature DB >> 23051885

Increased spontaneous gamma power and synchrony in schizophrenia patients having higher minor physical anomalies.

Sai Krishna Tikka1, Shamsul Haque Nizamie, Basudeb Das, Mohammad Zia Ul Haq Katshu, Nishant Goyal.   

Abstract

The higher frequency of minor physical anomalies (MPAs) in schizophrenia provides morphological evidence for the neurodevelopmental theory. Abnormal gamma oscillations (>30 Hz) seen in the electroencephalogram (EEG) in schizophrenia have been hypothesized to result from developmental insults. This study investigated spontaneous gamma oscillations in schizophrenia patients having higher and lower number of MPAs. Forty drug naïve/free schizophrenia patients and 20 matched healthy controls were assessed for MPAs on the Extended Waldrop Scale (EWS). All participants underwent an awake, resting 192-channel EEG recording. Spontaneous gamma spectral power and coherence were estimated in the low- (30-50 Hz) and high-gamma (51-70 and 71-100 Hz) bands. Significantly higher power was observed in high-MPA than healthy control group in low-gamma band over right frontal, parietal and temporal regions. Spectral power in the high-gamma band (71-100 Hz) was also significantly higher in the high-MPA schizophrenia subgroup than in the healthy control group over left frontal, parietal and temporal regions. Additionally, regional intra-hemispheric and inter-hemispheric coherence in the low-gamma band was significantly higher in the high-MPA schizophrenia subgroup than on the healthy control group. This study is the first to provide evidence of increased spontaneous gamma power and synchrony in schizophrenia patients having higher MPAs, supporting the idea that it may represent a distinct subgroup of schizophrenia with a neurodevelopmental basis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23051885     DOI: 10.1016/j.psychres.2012.09.006

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

2.  Gamma activity model for treatment-resistant bipolar psychotic mania.

Authors:  Shashi Ranjan Kumar; Vinod Kumar Sinha; Sai Krishna Tikka; Nishant Goyal
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

3.  Schneiderian first rank symptoms and gamma oscillatory activity in neuroleptic naïve first episode schizophrenia: a 192 channel EEG study.

Authors:  Sai Krishna Tikka; Shailly Yadav; Shamusul Haque Nizamie; Basudeb Das; Deyashini Lahiri Tikka; Nishant Goyal
Journal:  Psychiatry Investig       Date:  2014-10-20       Impact factor: 2.505

4.  Multisensory stimuli elicit altered oscillatory brain responses at gamma frequencies in patients with schizophrenia.

Authors:  David B Stone; Brian A Coffman; Juan R Bustillo; Cheryl J Aine; Julia M Stephen
Journal:  Front Hum Neurosci       Date:  2014-11-04       Impact factor: 3.169

5.  Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans.

Authors:  Sara de la Salle; Joelle Choueiry; Dhrasti Shah; Hayley Bowers; Judy McIntosh; Vadim Ilivitsky; Verner Knott
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

6.  Improving risk assessment and familial aggregation of age at onset in schizophrenia using minor physical anomalies and craniofacial measures.

Authors:  I-Ning Tsai; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Shu-Ting Gan; Sheng-Hsiang Lin
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome.

Authors:  Mélodie Proteau-Lemieux; Inga Sophia Knoth; Kristian Agbogba; Valérie Côté; Hazel Maridith Barlahan Biag; Angela John Thurman; Charles-Olivier Martin; Anne-Marie Bélanger; Cory Rosenfelt; Flora Tassone; Leonard J Abbeduto; Sébastien Jacquemont; Randi Hagerman; François Bolduc; David Hessl; Andrea Schneider; Sarah Lippé
Journal:  Front Psychiatry       Date:  2021-11-11       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.